CAPA Scope
Define the quality issue, affected products, sites, processes, and boundaries of the CAPA.
4.8
on G2
Free Pharma & Biotech Template
Corrective and preventive action plan for [quality_issue]
Use this template to corrective and preventive action plan for [quality_issue].
| Field | Details |
|---|---|
| Category | Pharma & Biotech |
| Owner | [Team or owner] |
| Version | [Version number] |
| Effective Date | [Date] |
| Review Cycle | [Monthly / Quarterly / Annual / Event-based] |
| Status | [Draft / In Review / Approved] |
Define the quality issue, affected products, sites, processes, and boundaries of the CAPA.
| Item | Details | Owner | Status |
|---|---|---|---|
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]
Reference deviations, audits, complaints, OOS events, or inspection observations that initiated the CAPA.
| Item | Details | Owner | Status |
|---|---|---|---|
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]
Summarize confirmed root cause and evidence supporting it.
| Item | Details | Owner | Status |
|---|---|---|---|
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]
Separate corrections, corrective actions, and preventive actions with owner, due date, and required records.
| Item | Details | Owner | Status |
|---|---|---|---|
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]
Define measurable criteria, sampling period, responsible reviewer, and failure response.
| Item | Details | Owner | Status |
|---|---|---|---|
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]
Explain interim controls and any quality risk management updates.
| Item | Details | Owner | Status |
|---|---|---|---|
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]
List required Quality, Manufacturing, Validation, or Regulatory approvals. Use Markdown tables and keep action descriptions auditable.
| Item | Details | Owner | Status |
|---|---|---|---|
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]
Template Structure
Use this pharma & biotech template as a starting point, then customize each section to match your internal workflow, evidence, and signoff needs.
Define the quality issue, affected products, sites, processes, and boundaries of the CAPA.
Reference deviations, audits, complaints, OOS events, or inspection observations that initiated the CAPA.
Summarize confirmed root cause and evidence supporting it.
Separate corrections, corrective actions, and preventive actions with owner, due date, and required records.
Define measurable criteria, sampling period, responsible reviewer, and failure response.
Explain interim controls and any quality risk management updates.
List required Quality, Manufacturing, Validation, or Regulatory approvals. Use Markdown tables and keep action descriptions auditable.
Write a pharmaceutical CAPA Plan. Structure with these Markdown sections:
Define the quality issue, affected products, sites, processes, and boundaries of the CAPA.
Reference deviations, audits, complaints, OOS events, or inspection observations that initiated the CAPA.
Summarize confirmed root cause and evidence supporting it.
Separate corrections, corrective actions, and preventive actions with owner, due date, and required records.
Define measurable criteria, sampling period, responsible reviewer, and failure response.
Explain interim controls and any quality risk management updates.
List required Quality, Manufacturing, Validation, or Regulatory approvals.
Use Markdown tables and keep action descriptions auditable.
This CAPA addresses repeated incomplete line clearance entries in packaging suite PKG-3.
Initiated from deviation DEV-2026-014 and internal audit observation IA-26-07.
The checklist did not require verification of obsolete label roll removal before startup.
| Type | Action | Owner | Due |
|---|---|---|---|
| Corrective | Retrain PKG-3 operators | Packaging Manager | 2026-05-12 |
| Preventive | Revise SOP PKG-012 | QA Documentation | 2026-05-18 |
QA will review 30 consecutive line clearances with zero missing entries.
Quality Unit approval is required before CAPA closure.
Record a walkthrough, training session, or process demonstration. Docsie AI turns it into structured documentation using this template as the starting framework.
Use the template manually, or let Docsie generate the first draft from source footage.
APQR report for [product_name] covering [review_period]
Controlled record for manufacturing [product] batch [batch_number]
Controlled assessment for proposed GMP change to [system_or_process]
Protocol for validating cleaning of [equipment_or_process_train]
GMP deviation investigation for [event] affecting [batch_or_process]
Controlled GMP procedure for [process_name]
Template FAQ
Common questions about using and generating a cAPA Plan.
Q: What is a cAPA Plan?
A: A cAPA Plan is a structured document for corrective and preventive action plan for [quality_issue].
Q: Can I download this cAPA Plan as Word or PDF?
A: Yes. This page includes free downloads in DOCX, PDF, and Markdown formats so you can edit, share, or import the template into your documentation system.
Q: Can Docsie generate this from a video?
A: Yes. Upload a process walkthrough, training recording, or screen capture to Docsie, then use this template structure to generate a first draft automatically.